96 International Utilization of SABR for Early-Stage NSCLC: Are We All Speaking the Same Language?

IF 4.9 1区医学 Q1 ONCOLOGY

Radiotherapy and Oncology Pub Date : 2024-09-01 DOI:10.1016/S0167-8140(24)03752-6

Salem Alfaifi, Alexander Louie, Shankar Siva, Matthias Guckenberger, Gregory Videtic, Faiz Alshafa, Hamza AlGhamdi, Kristin Higgins, Kevin Stephans, Erin Gillespie, Layth Mula-Hussain, Stephen Harrow, David Palma

引用次数: 0

查看原文本刊更多论文

96 国际上对早期 NSCLC 使用 SABR 的情况：我们说的是同一种语言吗？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Radiotherapy and Oncology 医学-核医学

CiteScore

10.30

自引率

10.50%

发文量

2445

审稿时长

45 days

期刊介绍： Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.